[ 1] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 2] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 3] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 4] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 5] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 6] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 7] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 8] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 9] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 10] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 11] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 12] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 13] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 14] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 15] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 16] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 17] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 18] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 19] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 20] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 21] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 22] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 23] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 24] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 25] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 26] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 27] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 28] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 29] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 30] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 31] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 32] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 33] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 34] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 35] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 36] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 37] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 38] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 39] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 40] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 41] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 42] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 43] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 44] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 45] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 46] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 47] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 48] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 49] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 50] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 51] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 52] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 53] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 54] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 55] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 56] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 57] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 58] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 59] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 60] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 61] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 62] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 63] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 64] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 65] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 66] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 67] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 68] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 69] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 70] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 71] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 72] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 73] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 74] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 75] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 76] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 77] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 78] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 79] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 80] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 81] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 82] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 83] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 84] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 85] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 86] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 87] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 88] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 89] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 90] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 91] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [ 92] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 93] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 94] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 95] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 96] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [ 97] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [ 98] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [ 99] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [100] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [101] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [102] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [103] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [104] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [105] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [106] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [107] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [108] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [109] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [110] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [111] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [112] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [113] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [114] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [115] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [116] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [117] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [118] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [119] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [120] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [121] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [122] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [123] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [124] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [125] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [126] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [127] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [128] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [129] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [130] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [131] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [132] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [133] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [134] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [135] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [136] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [137] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [138] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [139] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [140] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [141] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [142] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [143] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [144] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [145] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [146] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [147] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [148] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [149] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [150] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [151] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [152] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [153] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [154] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [155] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [156] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [157] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [158] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [159] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [160] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [161] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [162] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [163] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [164] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [165] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [166] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [167] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [168] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [169] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [170] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [171] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [172] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [173] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [174] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [175] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [176] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [177] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [178] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [179] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [180] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [181] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [182] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [183] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [184] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [185] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [186] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [187] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [188] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [189] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [190] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [191] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [192] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [193] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [194] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [195] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [196] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [197] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [198] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [199] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [200] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [201] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [202] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [203] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [204] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [205] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [206] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [207] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [208] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [209] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [210] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [211] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [212] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [213] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [214] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [215] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [216] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [217] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [218] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [219] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [220] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [221] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [222] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [223] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [224] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [225] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [226] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [227] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [228] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [229] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [230] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [231] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [232] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [233] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [234] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [235] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [236] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [237] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [238] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [239] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [240] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [241] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [242] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [243] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [244] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [245] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [246] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [247] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [248] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [249] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [250] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [251] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [252] Press Release (2026-01-30)/Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025". [253] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [254] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [255] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [256] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [257] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [258] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [259] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [260] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [261] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [262] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [263] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [264] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [265] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [266] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [267] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [268] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [269] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [270] Press Release (2026-01-30)/Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025". [271] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [272] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [273] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [274] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [275] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [276] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [277] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [278] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [279] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [280] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [281] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [282] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [283] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [284] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [285] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [286] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [287] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [288] Press Release (2026-01-30)/Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025". [289] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [290] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [291] Press Release (2026-02-13)/Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results". [292] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [293] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [294] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [295] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [296] Press Release (2026-02-05)/Suraksha Diagnostic Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Unaudited (standalone and consolidated) financial results of the Company for quarter and nine months ended 31 December 2025". [297] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [298] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [299] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [300] Press Release (2026-02-05)/Krsnaa Diagnostics Limited has informed the Exchange regarding a press release dated February 05, 2026, titled "Operationally Resilient Quarter with Seasonal Revenue Softness; Rajasthan Rollout to Drive Revenue Growth from Next Year". [301] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [302] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [303] Outcome of Board Meeting (2026-01-30)/Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended December 31, 2025. [304] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [305] Analysts/Institutional Investor Meet/Con. Call Updates (2026-02-02)/Thyrocare Technologies Limited has informed the Exchange about Transcript of Earnings Call held on January 28, 2026 [306] Press Release (2026-01-30)/Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025".